A new class of pyrazolo[5,1-c][1,2,4]triazines as γ-aminobutyric type A (GABAA) receptor subtype ligand: synthesis and pharmacological evaluation.

[1]  C. Martini,et al.  Synthesis and pharmacological evaluation of pyrazolo[1,5-a]pyrimidin-7(4H)-one derivatives as potential GABAA-R ligands. , 2017, Bioorganic & medicinal chemistry.

[2]  M. Chebib,et al.  GABAA Receptors and the Diversity in their Structure and Pharmacology. , 2017, Advances in pharmacology.

[3]  C. Martini,et al.  Pyrazolo[1,5-a]quinazoline scaffold as 5-deaza analogue of pyrazolo[5,1-c][1,2,4]benzotriazine system: synthesis of new derivatives, biological activity on GABAA receptor subtype and molecular dynamic study , 2016, Journal of enzyme inhibition and medicinal chemistry.

[4]  U. Rudolph,et al.  Behavioral functions of GABAA receptor subtypes--the Zurich experience. , 2015, Advances in pharmacology.

[5]  H. Möhler The legacy of the benzodiazepine receptor: from flumazenil to enhancing cognition in Down syndrome and social interaction in autism. , 2015, Advances in pharmacology.

[6]  C. Martini,et al.  Synthesis of novel cognition enhancers with pyrazolo[5,1-c][1,2,4]benzotriazine core acting at γ-aminobutyric acid type A (GABA(A)) receptor. , 2013, Bioorganic & medicinal chemistry.

[7]  C. Martini,et al.  Development of ligands at γ-aminobutyrric acid type A (GABAA) receptor subtype as new agents for pain relief. , 2011, Bioorganic & medicinal chemistry.

[8]  F. Knoflach,et al.  Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes , 2011, Nature Reviews Drug Discovery.

[9]  E. Novellino,et al.  New insight into the central benzodiazepine receptor-ligand interactions: design, synthesis, biological evaluation, and molecular modeling of 3-substituted 6-phenyl-4H-imidazo[1,5-a][1,4]benzodiazepines and related compounds. , 2011, Journal of medicinal chemistry.

[10]  C. Martini,et al.  Synthesis and benzodiazepine receptor affinity of pyrazolo[1,5-a]pyrimidine derivatives. 3. New 6-(3-thienyl) series as alpha 1 selective ligands. , 2003, Journal of medicinal chemistry.

[11]  E. Novellino,et al.  Novel N-(arylalkyl)indol-3-ylglyoxylylamides targeted as ligands of the benzodiazepine receptor: synthesis, biological evaluation, and molecular modeling analysis of the structure-activity relationships. , 2001, Journal of medicinal chemistry.

[12]  C. Martini,et al.  Synthesis and BZR affinity of pyrazolo[1,5-a]pyrimidine derivatives. Part 1: study of the structural features for BZR recognition. , 1999, Bioorganic & medicinal chemistry.

[13]  C. Martini,et al.  Benzodiazepine receptor ligands. 4. Synthesis and pharmacological evaluation of 3-heteroaryl-8-chloropyrazolo[5,1-c][1,2,4] benzotriazine 5-oxides. , 1999, Journal of medicinal chemistry.

[14]  C. Martini,et al.  Synthesis, benzodiazepine receptor affinity and in vivo testing of 3-aryl-4,7-dihydro-6-(N1′-alkylpyrazol-3′ - or 5′-yl)pyrazolo[1,5-a]pyrimidin-7-ones , 1998 .

[15]  C. Martini,et al.  New 2,3-substituted 4,7-dihydro-6-(1'H-pyrazol-3'-yl)pyrazolo[1,5-a] pyrimidin-7-ones and related compounds: synthesis and benzodiazepine receptor binding study. , 1995, Farmaco.

[16]  S. Selleri,et al.  Reactivity of 7‐(2‐dimethylaminovinyl)pyrazolo[1,5‐a]pyrimidines: Synthesis of pyrazolo[1,5‐a]pyrido[3,4‐e]pyrimidine derivatives as potential benzodiazepine receptor ligands. 2 , 1994 .

[17]  G. Bennett Lowry's handbook of right-to-know emergency planning : by G.G. Lowry and R.C. Lowry, Lewis Publishers, Chelsea, MI, 1988, ISBN 0-87371-112-2, 421 pp., $ 85.00. , 1992 .

[18]  C. Martini,et al.  Isolation of Putative Benzodiazepine Receptors from Rat Brain Membranes by Affinity Chromatography , 1982, Journal of neurochemistry.

[19]  R. K. Robins,et al.  Synthesis and enzymic activity of some novel xanthine oxidase inhibitors. 3-Substituted 5,7-dihydroxypyrazolo(1,5-alpha)pyrimidines. , 1976, Journal of medicinal chemistry.

[20]  Y. Cheng,et al.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. , 1973, Biochemical pharmacology.

[21]  J. Lafferty,et al.  SYNTHESIS AND MUSCLE RELAXANT PROPERTIES OF 3-AMINO-4-ARYLPYRAZOLES. , 1964, Journal of medicinal chemistry.

[22]  F. Effenberger,et al.  Säureamid-Reaktionen, XXXVIII. Umsetzungen von Kohlensäurederivaten und Aminen mit Formylierungsmitteln: Synthesen disubstituierter s-Triazine und trisubstituierter Formamidine , 1964 .

[23]  Reuben G. Jones,et al.  SUBSTITUTED β-AMINOETHYLPYRAZOLES , 1954 .

[24]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.